The House Appropriations Committee approved its FY 2019 spending bill including a $1.25 billion funding increase for the National Institutes of Health (NIH) and a $171 million funding boost for the National Cancer Institute (NCI). The bill also preserves funding for the CDC and Office on Smoking and Health (OSH)
Today a federal judge ruled the Department of Health and Human Services (HHS) failed to adequately consider how Kentucky’s proposed Medicaid work rules would effect residents’ access to health care as required under federal law.
The Senate Appropriations Committee approved its FY 2019 Labor, Health and Human Services spending bill today. The bill includes a $2 billion funding increase for the National Institutes of Health (NIH) and a $190 million funding boost for the National Cancer Institute (NCI).
The Centers for Medicare and Medicaid Services (CMS) announced today that they will not approve Massachusetts’ request to restrict Medicaid prescription drug coverage to as few as one drug per class—a practice commonly called a “closed formulary”—unless a state foregoes all manufacturer rebates.
The Department of Labor issued final rules governing the creation of association health plans. Under the rule, AHPs would be exempt from current benefit and cost-sharing requirements.
Patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae or friend of the court brief in the U.S. District Court case, Texas v. United States, citing the devastating impact patients would face should the court side with plaintiffs and move to invalidate the Affordable Care Act.
The Department of Justice (DOJ) announced last night it will not defend several critical patient protections in the health law and instead is arguing to end them. If successful, the case could leave millions of Americans with serious illnesses unable to obtain health care coverage.
American Cancer Society Cancer Action Network (ACS CAN) volunteers will head to Capitol Hill today with over 100 other cancer patients, survivors, caregivers, physicians and researchers representing more than 50 cancer organizations to share poll results that show overwhelming public support for continued robust and sustained federal investment in cancer research and urge lawmakers to make fighting cancer a top national priority.
Proposals expected to be announced as part of the administration's American Patients First plan, include various changes to Medicare’s prescription drug program, such as protecting beneficiaries from catastrophic costs through an out-of-pocket maximum, and requiring plans to share a minimum portion of drug rebates with patients.
Washington, D.C. - Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics